Call Us for Support
+91 9654860915
Google Reviews
4.8
Call Us for Support
+91 9654860915
.webp)
Sourced directly from the authorized manufacturer network to ensure authenticity and quality.
You can also access detailed information by clicking Login in the website header.
Supplied with complete CDSCO-approved import and customs documentation, including Form 12A & 12B, CDEC, GST Bill of Entry, Commercial Invoice, and Packing List.
Manufacturer / Innovator:
Germany
Regulatory Approval:
Your Trustedworthy Partner For Named Patient Program
Over a decade of trusted expertise in Named Patient Access to innovative and life-saving medicines.
100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.
Medicines sourced from authorized manufacturers with full batch traceability.
EU-GDP compliant warehousing for secure, quality-controlled global distribution.
Temperature-controlled logistics ensuring safe, reliable, and timely medicine delivery.
Bimzelx (bimekizumab-bkzx) is a humanized monoclonal antibody that selectively binds to and inhibits interleukin-17A (IL-17A), interleukin-17F (IL-17F), and IL-17AF, cytokines that drive inflammation in several chronic immune-mediated conditions. It is indicated for the treatment of adults with:
It is a prescription biologic and must be used under the supervision of a qualified dermatologist or rheumatologist.
Dosing varies by indication:
Bimzelx is supplied as a 100 mg or 160 mg subcutaneous injection (prefilled syringe or pen) and may be self-administered after proper training.
This information is not a treatment plan. For personalized medical advice, consult your doctor and refer to the full prescribing information.
Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.
Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.
Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.
Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.
Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant, cold-chain conditions to maintain product integrity.
Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.
Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.
Bimzelx (bimekizumab-bkzx) injection may be imported in the patient's name only, by patients or government hospitals. The following documentation is required:
The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.
Bimzelx (bimekizumab-bkzx injection) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Bimzelx is not commercially marketed in India.
However, patients in India can legally access Bimzelx through the Named Patient Program (NPP) — an import provision that allows a medicine not yet registered in India to be imported in the name of a specific patient for their personal treatment, under a valid prescription. NPP facilitates this regulated import pathway for patients across India.
Bimzelx is approved in several markets, including the United States, the European Union, Canada, and Australia, ensuring full transparency throughout the process.
Bimzelx can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others — and can facilitate delivery to the patient's treating hospital. Orders are confirmed only after receipt of a valid doctor's prescription and an import permit, where applicable.
Bimzelx is available in two strengths — 100 mg and 160 mg — with the appropriate strength and pack sourced according to prescription and availability.
NamedPatientProgram.com (NPP) can source Bimzelx from reliable global channels and facilitate supply to patients, doctors, and hospitals under applicable legal provisions. As a temperature-sensitive biologic, Bimzelx requires cold-chain handling throughout transit and must be kept refrigerated between 2°C to 8°C until use. All prescriptions are dispensed and checked by registered pharmacists and dispatched from New Delhi, India, after legal requirements are fulfilled.
Bimzelx is available in two strengths: 160 mg (sourced from Germany) and 100 mg (sourced from India), each with its own indicative pricing. For the current Bimzelx cost in India for either strength and availability, contact NPP via WhatsApp at +91 98104 69557 | Toll-Free: 1800-1200-365 or email info@namedpatientprogram.com.
Patients across India can access Bimzelx through regulated import pathways, with delivery arranged to the treating hospital or patient based on a valid dermatologist's or rheumatologist's prescription.
A major healthcare hub with leading dermatology and rheumatology centers, Mumbai sees steady demand for advanced biologics like Bimzelx for psoriasis and psoriatic arthritis.
As part of the Delhi NCR region, the city has a strong concentration of dermatology and rheumatology specialists, making it a key location for accessing advanced immunology therapies.
With a growing network of multispecialty hospitals, Bangalore supports access to global immunology treatments through structured import pathways guided by treating specialists.
Home to several reputed dermatology and rheumatology practices, Chennai facilitates access to Bimzelx for patients with plaque psoriasis, axial spondyloarthritis, and hidradenitis suppurativa.
A growing hub for specialty care, Hyderabad supports coordinated access to Bimzelx for patients under specialist supervision.
Eastern India's leading medical centers in Kolkata coordinate Bimzelx access for patients with chronic inflammatory skin and joint conditions.
With an expanding base of dermatology and rheumatology clinics, Pune facilitates timely access to Bimzelx under prescription.
Gujarat's leading hospitals support regulated access to Bimzelx for eligible patients.
Kerala's healthcare network, including major hospitals in Kochi, coordinates access to advanced biologics like Bimzelx.
Serving North India, Chandigarh's specialist centers facilitate access to Bimzelx for patients from Punjab, Haryana, and Himachal Pradesh.
Rajasthan's leading hospitals support patient access to Bimzelx through the Named Patient Program.
A key referral center for North India, Lucknow facilitates coordinated access to Bimzelx under specialist care.
Odisha's growing specialty healthcare sector supports patient access to Bimzelx.
As a referral hub for the North-East, Guwahati facilitates access to Bimzelx for patients across the region.
Access can also be coordinated for patients in other major Indian cities, subject to a valid prescription and regulatory requirements.
Written By: Nitin Goswami, Senior Medical Content Writer
Last Updated: 08 September 2026
Sources: FDA • EMA • CDSCO
Medically Reviewed By: Shilpi Banerjee, Registered Pharmacist (M.Pharm)
Last Updated: 08 September 2026
Our specialists are here to guide you through every step of the medicine access process.
Mail Us At:
info@namedpatientprogram.comContact Us:
+91 9654860915Send us a message
